Patent · US Active

Heterocyclic compounds which modulate the CB2 receptor

US8889670B2 · kind B2 · utility

6Cited by

18References

13Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Alessandra Bartolozzi · Norwalk, US
Angela Berry · Gaylordsville, US
Pier Francesco Cirillo · Woodbury, US
Eugene Richard Hickey · Danbury, US
Doris Riether · Biberach an der Riß, DE
Lifen Wu · New Milford, US
Renee M. Zindell · New Milford, US

Key dates

Filing date	Feb 16, 2010
Grant date	Nov 18, 2014
Priority date	—
Expiry date	Aug 29, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds which modulate the CB2 receptor are disclosed. Compounds according to the invention bind to and are agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.